Evaluation of a New Laboratory Test Measuring Plasma (1.RAR.3)-.BETA.-D-glucan in the Diagnosis of Candida Deep Mycosis: Comparison with a Serologic Test.

Accession number;99A0269801
Title;Evaluation of a New Laboratory Test Measuring Plasma (1.RAR.3)-.BETA.-D-glucan in the Diagnosis of Candida Deep Mycosis: Comparison with a Serologic Test.
Author; HIYOSHI M (Osaka City Univ., Osaka, Jpn) TAGAWA S (Osaka City Univ., Osaka, Jpn) HASHIMOTO S (Osaka City Univ., Osaka, Jpn) SAKAMOTO C (Osaka City Univ., Osaka, Jpn) TATSUMI N (Osaka City Univ., Osaka, Jpn)
Journal Title;Journal of the Japanese Association for Infectious Diseases
Journal Code:Z0760A
ISSN:0387-5911
VOL.73;NO.1;PAGE.1-6(1999)
Figure&Table&Reference;FIG.2, TBL.1, REF.16
Pub. Country;Japan
Language;English
Abstract;We evaluated the effectiveness of the newly developed WAKO .BETA.-glucan test which measures plasma (1.RAR.3)-.BETA.-D-glucan concentrations in the diagnosis of Canada deep mycosis. This test was compared to the Cand-Tec test. The WAKO .BETA.-glucan test and Cand-Tec test were performed on 212 plasma specimens which were taken at 212 instances from 62 immunocompromised patients with serious diseases; i.e. hematopoietic malignancy, solid malignant tumor, etc. The sensitivities and specificities for the WAKO .BETA.-glucan test were 84.8 and 85.9%, respectively, and 60.9 and 80.0% for the Cand-Tec test. (author abst.)